Table 3 Comparison of the anti-JCV antibody status between MS patients with and without fingolimod treatment

History of fingolimod treatment

Yes (n = 83)

No (n = 45)

p value

  Anti-JCV antibody, positive

59 (71.1%)

27 (60.0%)

0.239

  Anti-JCV antibody index

1.40 [0.26–3.18]

0.57 [0.16–2.97]

0.129

Fingolimod treatment at sampling

Yes (n = 64)

No (n = 64)

p value

  Anti-JCV antibody, positive

47 (73.4%)

39 (60.9%)

0.187

  Anti-JCV antibody index

1.46 [0.34–3.26]

0.64 [0.16–2.61]

0.039